Last reviewed · How we verify

NCT02523066

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients

Terminated Last updated 18 May 2025
What this trial tests

trial testing Magna Ease in Mitral Valve or Aortic Valve Replacement in 215 participants. Terminated before completion.

Timeline
10 November 2014
Primary endpoint
29 April 2017
7 May 2025

Quick facts

Lead sponsorEdwards Lifesciences
StatusTerminated
Study typeOBSERVATIONAL
Enrollment215
Start date10 November 2014
Primary completion29 April 2017
Estimated completion7 May 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Edwards Lifesciences — full company profile →

Who can join

Eligibility, any sex, with Mitral Valve or Aortic Valve Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Edwards Lifesciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02523066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing